Abstract
Primary breast lymphoma (PBL) is a rare form of extranodal non-Hodgkin’s lymphoma (NHL), whose own specific biological characteristics still need to be fully defined. No significant prognostic factor has been found and the optimal therapeutic strategy is uncertain. However, an intensified systemic therapy has been advocated to prevent relapse, even in patients who show a complete response to local treatment. We report two cases of primary diffuse large B-cell breast lymphoma, review the literature about this topic, and discuss treatment options. We conclude that differential therapeutic strategies based on the risk of relapse associated with the International Prognostic Index (IPI) are a reasonable way to approach PBL, and can avoid undue toxicity deriving from treatment.
Similar content being viewed by others
Abbreviations
- PBL:
-
Primary breast lymphoma
- NHL:
-
Non Hodgkin’s lymphoma
- CNS:
-
Central nervous system
- IPI:
-
International Prognostic Index
- LDH:
-
Lactate dehydrogenase
- ECOG:
-
Eastern Cooperative Oncology Group
- CHOP:
-
Cyclophosphamide, doxorubicin, vincristine, and prednisolone
References
Gholam D, Bibeau F, El Weshi A, Bosq J, Ribrag V. Primary breast lymphoma. Leuk Lymphoma. 2003;44:1173–8.
Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer. 1972;29:1705–12.
Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP. Lymphomas of the breast: primary and secondary involvement. Cancer. 2002;94:6–13.
Barista I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozisik Y, et al. Primary breast lymphomas-a retrospective analysis of twelve cases. Acta Oncol. 2000;39:135–9.
Brogi E, Harris NL. Lymphomas of the breast: pathology and clinical behavior. Semin Oncol. 1999;26:357–64.
Ryan GF, Martinelli G, Yuen K, Seymour J. Primary non-Hodgkin’s lymphoma of the breast: first report of the multicentre retrospective study of the International Extranodal Lymphoma Study Group (IELSG-15). J Clin Oncol. 2005;16:6575a.
Yoshida S, Nakamura N, Sasaki Y, Yoshida S, Yasuda M, Sagara H, et al. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype. Mod Pathol. 2005;18:398–405.
Liberman L, Giess CS, Dershaw DD, Louie DC, Deutch BM. Non-Hodgkin lymphoma of the breast: imaging characteristics and correlation with histopathologic findings. Radiology. 1994;192:157–60.
Lieberman HB. DNA damage repair and response proteins as targets for cancer therapy. Curr Med Chem. 2008;15:360–7.
Krishnan B, Morgan GJ. Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomarkers Prev. 2007;16:377–80.
Duncan VE, Reddy VV, Jhala NC, Chhieng DC, Jhala DN. Non-Hodgkin’s lymphoma of the breast: a review of 18 primary and secondary cases. Ann Diagn Pathol. 2006;10:144–8.
Hugh JC, Jackson FI, Hanson J, Poppema S. Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer. 1990;66:2602–11.
Zinzani PL, Magagnoli M, Frezza G, Prologo G, Gherlinzoni F, Bendandi M, et al. Isolated central nervous system relapse in aggressive non-Hodgkin’s lymphoma: the Bologna experience. Leuk Lymphoma. 1999;32:571–6.
Tondini C, Ferreri AJ, Siracusano L, Valagussa P, Giardini R, Rampinelli I, et al. Diffuse large-cell lymphoma of the testis. J Clin Oncol. 1999;17:2854–8.
National Comprehensive Cancer Network. Non-Hodgkin’s Lymphoma V.3.2007. NCCN Clinical Practice Guidelines in Oncology 2007: http://www.nccn.org/professionals/physician_gls/PDF/nhl.pdf. Accessed 28 Dec 2007.
Carver JR, Shapiro CL, Ng A, Jacobs L, Schwartz C, Virgo KS, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac, pulmonary late effects. J Clin Oncol. 2007;25:3991–4008.
Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290:465–75.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stasi, R., Evangelista, M.L., Brunetti, M. et al. Analysis of differential therapeutic strategies for primary breast lymphoma: two case reports. Med Oncol 26, 22–26 (2009). https://doi.org/10.1007/s12032-008-9073-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-008-9073-z